NPI: 1184691503 · PALM SPRINGS, FL 33406 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/03/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/03/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 14,488 | $2.17M |
| 2019 | 27,437 | $2.57M |
| 2020 | 30,207 | $4.08M |
| 2021 | 29,352 | $1.63M |
| 2022 | 21,434 | $1.94M |
| 2023 | 2,401 | $250K |
| 2024 | 1,167 | $99K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 35,879 | 2,375 | $4.25M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 39,654 | 1,882 | $3.63M |
| J1270 | Injection, doxercalciferol, 1 mcg | 23,534 | 1,589 | $1.90M |
| A4657 | Syringe, with or without needle, each | 6,572 | 1,982 | $1.06M |
| J1756 | Injection, iron sucrose, 1 mg | 7,916 | 1,465 | $602K |
| 83970 | 2,298 | 1,306 | $247K | |
| 85041 | 2,096 | 1,399 | $206K | |
| 85048 | 2,097 | 1,398 | $203K | |
| 82728 | 1,565 | 1,030 | $161K | |
| 83540 | 1,584 | 1,037 | $158K | |
| 83550 | 1,580 | 1,037 | $157K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 608 | 359 | $57K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 422 | 160 | $52K |
| 82607 | 141 | 98 | $12K | |
| 82746 | 143 | 99 | $12K | |
| 82108 | 152 | 107 | $11K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 92 | 55 | $9K |
| G0008 | Administration of influenza virus vaccine | 86 | 65 | $7K |
| 90674 | 24 | 15 | $2K | |
| 90662 | 17 | 13 | $2K | |
| 0001A | 26 | 17 | $114.34 |